4.7 Review

Understanding the Potential of Genome Editing in Parkinson's Disease

期刊

出版社

MDPI
DOI: 10.3390/ijms22179241

关键词

gene editing; CRISPR; Cas; Parkinson's disease; delivery vehicles; nanostructured materials; clinical trials; gene therapy

资金

  1. University of Los Andes [120484467666]

向作者/读者索取更多资源

CRISPR is a popular gene-editing technique with potential applications in researching and treating neurodegenerative diseases, particularly Parkinson's disease. Gene therapy could offer new treatment alternatives and have significant potential in future research.
CRISPR is a simple and cost-efficient gene-editing technique that has become increasingly popular over the last decades. Various CRISPR/Cas-based applications have been developed to introduce changes in the genome and alter gene expression in diverse systems and tissues. These novel gene-editing techniques are particularly promising for investigating and treating neurodegenerative diseases, including Parkinson's disease, for which we currently lack efficient disease-modifying treatment options. Gene therapy could thus provide treatment alternatives, revolutionizing our ability to treat this disease. Here, we review our current knowledge on the genetic basis of Parkinson's disease to highlight the main biological pathways that become disrupted in Parkinson's disease and their potential as gene therapy targets. Next, we perform a comprehensive review of novel delivery vehicles available for gene-editing applications, critical for their successful application in both innovative research and potential therapies. Finally, we review the latest developments in CRISPR-based applications and gene therapies to understand and treat Parkinson's disease. We carefully examine their advantages and shortcomings for diverse gene-editing applications in the brain, highlighting promising avenues for future research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据